Epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors
Exkivity
Composition
- Active ingredients
- MOBOCERTINIB SUCCINATE EQ 40MG BASE
Official product information
Drugs@FDA lists the approved labels, letters and reviews for application NDA215310.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Brand name
- Exkivity
- Active substance
- mobocertinib succinate
- Drug class
- Epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors
- Group
- Kinase inhibitors
- Route
- Oral
- Dosage form
- Capsule
- Applicant
- Takeda Pharms USA
- Status
- Discontinued